about
Survivors of childhood cancer have increased risk of gastrointestinal complications later in lifeA prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapyRadiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosisOligometastasis and oligo-recurrence: more than a mirageTransarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developmentsReview and uses of stereotactic body radiation therapy for oligometastasesTransarterial therapy: an evolving treatment modality of hepatocellular carcinomaManagement of hepatocellular carcinoma with portal vein thrombosisRadioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectivesHepatic radiation toxicity: avoidance and ameliorationSynthetic nanoparticles for delivery of radioisotopes and radiosensitizers in cancer therapyDefibrotide in the treatment of hepatic veno-occlusive diseaseMinimally invasive image-guided therapies for hepatocellular carcinomaA Review of Radiation-Induced Coagulopathy and New Findings to Support Potential Prevention Strategies and TreatmentsEvaluation of contrast-enhanced ultrasonography for hepatocellular carcinoma prior to and following stereotactic body radiation therapy using the CyberKnife® system: A preliminary report.Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today?Increased Expression of Connective Tissue Growth Factor (CTGF) in Multiple Organs After Exposure of Non-Human Primates (NHP) to Lethal Doses of Radiation.Durable donor engraftment after radioimmunotherapy using α-emitter astatine-211-labeled anti-CD45 antibody for conditioning in allogeneic hematopoietic cell transplantationSplenomegaly-associated thrombocytopenia after hepatic yttrium-90 radioembolization.Significance of an increase in the Child-Pugh score after radiotherapy in patients with unresectable hepatocellular carcinomaImaging for assessment of radiation-induced normal tissue effectsCurative effect of stereotactic body radiotherapy for unresectable massive primary liver cancer.Stem cell therapies for the treatment of radiation-induced normal tissue side effects.Bone marrow-derived stromal cell therapy in cirrhosis: clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma.Comparison of coplanar and noncoplanar intensity-modulated radiation therapy and helical tomotherapy for hepatocellular carcinoma.Radiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases.Estimating functional liver reserve following hepatic irradiation: adaptive normal tissue response modelsBarriers to the successful treatment of liver disease by hepatocyte transplantation.Treating cancer patients. Practical monitoring and management of therapy-related complications.Curative effect of stereotactic body radiotherapy on hepatic hilar carcinoma.Amplification of engrafted hepatocytes by preparative manipulation of the host liver.Prospective randomized trial of enoxaparin, pentoxifylline and ursodeoxycholic acid for prevention of radiation-induced liver toxicity.High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma.Transarterial therapies for hepatocellular carcinoma.Quantitative in vivo assessment of radiation injury of the liver using Gd-EOB-DTPA enhanced MRI: tolerance dose of small liver volumes.Sinusoidal obstruction syndrome (hepatic veno-occlusive disease)Volumetric intensity-modulated Arc (RapidArc) therapy for primary hepatocellular carcinoma: comparison with intensity-modulated radiotherapy and 3-D conformal radiotherapyLiver regeneration and energetic changes in rats following hepatic radiation therapy and hepatocyte transplantation by ³¹P MRSIThe role of radiotherapy in the treatment of hepatocellular carcinoma with portal vein tumor thrombus.Radiation-associated liver injury.
P2860
Q24608553-F515A660-C670-4A4E-B21F-5428678FA4D8Q24811929-CED2C175-C99F-4CC9-BA2A-E93B0B9ECAC2Q26738533-BD6B6F2E-0FF1-47B0-9868-53704F7F105DQ26828767-E496BF3E-7496-41D3-B70A-9C4515A5BF50Q26852174-77A891F0-00C0-4560-8258-AFE63D214E72Q26864247-93AA3D41-965F-4868-977F-C16A361C4A63Q26866514-F5EC874A-223A-4DA9-8894-8F64057D0FDEQ26996578-333BEE46-BE3F-4A9F-AC97-20DC9BC8306AQ27023616-C9DB4B1C-B5A9-4FF7-91B5-28AC5B7C47CCQ27023687-355D52D2-B329-4053-B765-6FCC88F5ACE3Q28066010-F5E047E6-51A6-4FCA-9D67-9A9467457BBFQ28068332-B4DC611F-980C-42BB-AB15-ABC94C26F9CCQ28079027-B0ABF75F-C8A6-420F-8442-D24E2321EF28Q28828539-320FBD70-B8C4-4387-944E-3D330C3A991FQ30391291-11BD5D31-E2F1-487F-8A9A-CE1239ED37BAQ30468280-72998EBD-519A-40B1-A5B3-2702BE8B8B1EQ33390722-17CAF13C-F62B-412D-B5F1-DCC5476340BBQ33398529-366849E7-FA65-47A3-9AB1-F9C258AED727Q33410714-70322CF1-4CF1-4666-81B1-8879629BE66CQ33593108-2964F33B-E063-4EF9-B624-89D46FC9A41EQ33744357-9483175F-B342-43B7-B8C8-4B8F515322DBQ33748365-9FE01C65-3970-4734-87E8-DC387FD4AC93Q33768112-FD216FD1-C068-4152-A164-606281AE6E21Q33818431-29E20D4F-AEC7-4884-A316-E74550524310Q33894890-F92214A4-EBCB-4D0A-B4CE-E4E9331EA6DBQ33922093-6CFA113A-2042-4692-AC01-0C63EE0E5BF7Q33992068-5ADF9B6A-A893-4F5F-B6EA-938202CE00F3Q34091618-DE6E4959-AADB-444E-AC82-5202FDE32445Q34121459-B9A3399E-59DD-469A-9718-6462103FF0C1Q34265934-B31E5B6C-F07E-4628-8D3D-C2DBD74FE003Q34329968-1325779F-EC87-408C-8536-301FBAE3ADB2Q34506324-48CB41CB-9F22-421F-A4D3-F9996DF1EF7AQ34508914-1C3FEC06-E9AD-4F26-BDA4-5E2F6E48A462Q34628257-1E5AB324-6427-487A-BA2F-AC2AA578BEA8Q34957175-883344B5-19D0-4BDA-95BE-91D268FBC1F7Q34983459-828AD5F9-DBE3-414D-8F4D-2753592C0EBAQ35111353-5EA18FDC-1187-46A5-ACD4-D2226D7875DCQ35186391-1BC3CDB8-889C-404B-B55A-C6F29424DB88Q35234037-35A40078-BEF4-4E89-B020-DCAE661E5A17Q35297759-02BE325C-3F24-4BCE-A02D-3A4FD1B53B12
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Hepatic toxicity resulting from cancer treatment.
@en
type
label
Hepatic toxicity resulting from cancer treatment.
@en
prefLabel
Hepatic toxicity resulting from cancer treatment.
@en
P2093
P1476
Hepatic toxicity resulting from cancer treatment
@en
P2093
Ensminger WD
Fajardo LF
Lawrence TS
Robertson JM
P304
P356
10.1016/0360-3016(94)00418-K
P407
P577
1995-03-01T00:00:00Z